[go: up one dir, main page]

GB201304599D0 - Dosing regimen - Google Patents

Dosing regimen

Info

Publication number
GB201304599D0
GB201304599D0 GB201304599A GB201304599A GB201304599D0 GB 201304599 D0 GB201304599 D0 GB 201304599D0 GB 201304599 A GB201304599 A GB 201304599A GB 201304599 A GB201304599 A GB 201304599A GB 201304599 D0 GB201304599 D0 GB 201304599D0
Authority
GB
United Kingdom
Prior art keywords
dosing regimen
regimen
dosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201304599A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cyclacel Ltd
Original Assignee
Cyclacel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cyclacel Ltd filed Critical Cyclacel Ltd
Priority to GB201304599A priority Critical patent/GB201304599D0/en
Publication of GB201304599D0 publication Critical patent/GB201304599D0/en
Priority to PCT/GB2013/051236 priority patent/WO2013171473A1/en
Priority to EP13725424.9A priority patent/EP2874631A1/en
Priority to US14/401,357 priority patent/US9872874B2/en
Priority to JP2015512121A priority patent/JP6286421B2/en
Ceased legal-status Critical Current

Links

GB201304599A 2012-05-15 2013-03-14 Dosing regimen Ceased GB201304599D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB201304599A GB201304599D0 (en) 2013-03-14 2013-03-14 Dosing regimen
PCT/GB2013/051236 WO2013171473A1 (en) 2012-05-15 2013-05-14 Dosage regimen for sapacitabine and seliciclib
EP13725424.9A EP2874631A1 (en) 2012-05-15 2013-05-14 Dosage regimen for sapacitabine and seliciclib
US14/401,357 US9872874B2 (en) 2012-05-15 2013-05-14 Dosage regimen for sapacitabine and seliciclib
JP2015512121A JP6286421B2 (en) 2012-05-15 2013-05-14 Administration regimen of sapacitabine and sericivrib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201304599A GB201304599D0 (en) 2013-03-14 2013-03-14 Dosing regimen

Publications (1)

Publication Number Publication Date
GB201304599D0 true GB201304599D0 (en) 2013-05-01

Family

ID=48226314

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201304599A Ceased GB201304599D0 (en) 2012-05-15 2013-03-14 Dosing regimen

Country Status (1)

Country Link
GB (1) GB201304599D0 (en)

Similar Documents

Publication Publication Date Title
ZA201902009B (en) Anti-folr1 immunocunjugate dosing regimens
PL2798995T3 (en) Dosing device
GB201305308D0 (en) Packaging
SG11201508538SA (en) Complex
GB201313618D0 (en) Package
GB201321696D0 (en) Packaging
PL3077296T3 (en) Packaging
EP2985238A4 (en) Package
AU357268S (en) Packaging
PL3030193T3 (en) Dosing apparatus
GB2523532B (en) Packaging
HUE041387T2 (en) Flowmeter
GB201320744D0 (en) Packaging
EP2969903A4 (en) Intermittent dosing
GB201301046D0 (en) Dosing mechanism
GB201317415D0 (en) Packaging
GB201307175D0 (en) Packaging
GB201304599D0 (en) Dosing regimen
GB2510863B (en) Package
GB2526042B (en) Packaging
GB2513308B (en) Packaging
GB201208536D0 (en) Dosing regimen
GB201311472D0 (en) Packaging T9
ZA201508049B (en) Packaging
TWM475576U (en) Dosing system

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)